Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2COVID-19 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Teratoma 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Renal Insufficiency, Chronic 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Mouth Neoplasms 1

Interventions

Specimen Handling 38Biopsy 30Magnetic Resonance Spectroscopy 24pembrolizumab 14trastuzumab deruxtecan 8Radiosurgery 8Nivolumab 8Gemcitabine 8Paclitaxel 7Ipilimumab 6Carboplatin 6Capecitabine 6palbociclib 5X-Rays 5Taxes 5Radiation 5Leucovorin 5Fulvestrant 5Fluorouracil 5Pemetrexed 4Oxaliplatin 4Letrozole 4Irinotecan 4CTLA-4 Antigen 4Bevacizumab 4130-nm albumin-bound paclitaxel 4ribociclib 3olaparib 3ipatasertib 3enzalutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Practice Guidelines as Topic × 30 days × Clear all
NCT06745024 2026-05-04

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

NRG Oncology

Phase 3 Active not recruiting
280 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡